Skip to content

Study of tumour budding and immunoexpression of CD44 and TROP 2 in Oral Squmaous Cell Carcinoma

Study of tumour budding and immunoexpression of CD44 and TROP 2 in Oral Squmous Cell Carcinoma - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110185
Enrollment
50
Registered
2026-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Control Intervention1: NIL: NIL

Sponsors

Datta Meghe Institute Of Higher Education and Research DMIHER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.The biopsy diagnosed as oral squamous cell carcinoma. 2.The specimen diagnosed, the patients who are diagnosed as oral squamous cell carcinoma. 3.The patients with the histological diagnosis of oral squamous cell carcinoma. 4.The patients with the histological diagnosis of oral squamous cell carcinoma irrespective of grade of tumour. 5.The patients having adequate clinical details in regard of the oral squamous cell carcinoma.

Exclusion criteria

Exclusion criteria: 1. The patients diagnosed of oral squamous cancer of oral cavity other than squamous cell carcinomas. 2.The patients having inadequate details pertaining to histopathological diagnosis. 3. The patients having inadequate tumour tissue block which are inadeqaute to be porocessed for immunostaining for CD44 and TROP2

Design outcomes

Primary

MeasureTime frame
This study involves research on tumour budding and investigates the immunoexpression of CD44 and TROP2 in oral squamous cell carcinoma (OSCC) tumour cells and examines their correlation with tumor grade T, lymph node status N and metastatsis M.Timepoint: Assessment will be done at 12 months.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactAditya Walke

Datta Meghe Institute of Higher Education and Research (DMIHER)

aravani@rediffmail.com9822684255

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026